ImmuCell Corporation
ICCC
$9.89
-$0.02-0.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 787.50K | -545.30K | -1.04M | 2.32M | 1.76M |
| Total Depreciation and Amortization | 2.38M | 2.58M | 2.73M | 2.70M | 2.69M |
| Total Amortization of Deferred Charges | 39.20K | 46.80K | 54.40K | 62.00K | 43.20K |
| Total Other Non-Cash Items | 3.16M | 2.92M | 2.78M | -20.40K | 112.30K |
| Change in Net Operating Assets | -477.00K | -527.90K | -2.05M | -3.07M | -2.08M |
| Cash from Operations | 5.89M | 4.47M | 2.48M | 1.99M | 2.53M |
| Capital Expenditure | -1.68M | -1.10M | -1.25M | -1.27M | -768.90K |
| Sale of Property, Plant, and Equipment | 16.90K | 46.10K | 36.10K | 31.10K | 29.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.66M | -1.05M | -1.21M | -1.24M | -739.60K |
| Total Debt Issued | 801.30K | 801.30K | 801.30K | 801.30K | -- |
| Total Debt Repaid | -2.32M | -2.30M | -2.28M | -2.26M | -1.50M |
| Issuance of Common Stock | 165.00K | 329.90K | 349.30K | 888.60K | 4.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.60K | -39.50K | -82.50K | -98.70K | -194.90K |
| Cash from Financing | -1.37M | -1.21M | -1.21M | -668.80K | 2.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.86M | 2.21M | 48.50K | 77.50K | 4.67M |